UnitedHealth Group, US91324P1021

UnitedHealth Group with clear analyst backing, shares hold in the Dow Jones elite

22.06.2026 - 20:37:34 | ad-hoc-news.de

UnitedHealth Group starts the week with a solid consensus backdrop. JPMorgan and Bank of America reiterate positive views on the Dow Jones healthcare heavyweight, while the shares trade around 401 dollars on the NYSE.

UnitedHealth Group, US91324P1021
UnitedHealth Group, US91324P1021

By Christina Vogel, Background & Management desk. Reviewed prior to publication on 2026-06-22, 20:24.

UnitedHealth Group (US91324P1021) opens the new week as one of the key healthcare names in the Dow Jones Industrial Average and on the NYSE. Analysts at JPMorgan Chase and Bank of America continue to back the stock with positive recommendations, according to recent broker commentary and conference appearances.

What recent analyst notes show

UnitedHealth Group remains firmly in Buy territory at JPMorgan Chase, with the US bank reiterating its positive stance on 8 June 2026 and highlighting the company’s diversified earnings base across insurance and healthcare services. This view is reflected in recent summaries of broker actions on MarketScreener, where JPMorgan’s rating for UnitedHealth is listed as a Buy with an overweight positioning within the US healthcare sector. MarketScreener’s broker overview documents the June update by JPMorgan in the context of broader coverage of the stock.

Bank of America has also expressed confidence in UnitedHealth Group this month, emphasizing that the company stands to benefit from utilization trends in US healthcare and from the adoption of artificial intelligence in claims management and care coordination. A German-language summary on finanzen100 notes that Bank of America has upgraded its view on UnitedHealth and discusses the potential for a renewed rally in the shares if operational trends remain supportive. The finanzen100 article on UnitedHealth and AI highlights how the broker sees long-term structural drivers in data-driven healthcare.

Consensus and valuation snapshot today

Across Wall Street, the consensus picture for UnitedHealth Group remains robust, with a broad majority of analysts rating the stock at Buy and only a small minority sitting at Hold, according to current consensus compilations. MarketScreener’s data for 22 June 2026 show that UnitedHealth trades around 400.96 dollars on the NYSE, implying a forward price-to-earnings multiple that reflects both its defensive cash flow profile and its exposure to growth pockets in healthcare services. The live quote and consensus section on MarketScreener lists the latest price, daily move and aggregated ratings for UnitedHealth among its Dow Jones peers.

For European investors trading via Tradegate in Germany, UnitedHealth Group also appears regularly on watchlists. As of the latest intraday indication, Tradegate quotes show a bid price around 349.40 euros for the shares, with moderate spreads and volumes that mirror the underlying NYSE activity. The German portal Börsennews records UnitedHealth as part of the Gesundheitsdienstleistungen segment and notes that more than 5,000 users have the stock on their watchlist, underlining its popularity among retail investors. The Börsennews profile for UnitedHealth lists the ISIN US91324P1021, WKN 869561 and the latest Tradegate quote.

Go deeper

All news and analysis on the UnitedHealth Group shares

Further company reports, price data and analyst commentary on UnitedHealth Group can be found in the dedicated topic section on ad-hoc-news.de and on the company’s own investor relations pages.

How UnitedHealth Group makes its money

UnitedHealth Group generates most of its revenue through two main platforms: UnitedHealthcare, its health benefits business, and Optum, its health services arm. UnitedHealthcare provides health insurance coverage for employers, individuals and public programs such as Medicare and Medicaid in the United States and selected international markets, offering a broad range of medical, dental and supplemental plans. Optum contributes via Optum Health, Optum Insight and Optum Rx, delivering services from primary and specialty care to data analytics and pharmacy benefit management for payers, providers, employers and consumers.

Where the UnitedHealth shares trade today

The UnitedHealth Group shares (US91324P1021) trade on the NYSE under the ticker UNH at 400.96 dollars as of 2026-06-22, 11:07 Eastern Time, according to recent quote data, and are also available in Europe on Tradegate in euros for German investors.

Key data on the UnitedHealth Group shares

  • Company: UnitedHealth Group Incorporated
  • ISIN: US91324P1021
  • WKN: 869561
  • Ticker: UNH
  • Trading venue: NYSE
  • Price (as of 2026-06-22, 11:07): 400.96 USD
  • Market cap: around 370 billion USD (as of 2026-06-22)
  • Sector / industry: Health Care / Managed Health Care and Health Services
  • Index membership: Dow Jones Industrial Average, S&P 500, S&P 100
  • Next earnings date: 2026-07-18 (company guidance and calendar indications)

More on the UnitedHealth Group shares in social media

Disclaimer: This article is for informational purposes only and does not constitute investment advice, a recommendation to buy or sell any financial instrument, or any form of personal investment guidance. All data are based on sources believed to be reliable at the time of publication but are not guaranteed for accuracy or completeness.

en | US91324P1021 | UNITEDHEALTH GROUP | boerse | 69605560 | bgmi